Longeveron Statistics
NASDAQ: LGVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.48+0.11 (+4.64%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Longeveron by the numbers
Longeveron has a market capitalization of $7.9 million based on 3.04M shares outstanding. With trailing EPS of $-9.90, Longeveron is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 56.8% below its 50-day average and 64.3% below its 200-day average.
Average daily trading volume is 93.67K shares, or about $232,292 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LGVN valuation vs. peer median
| Metric | LGVN | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.91M | $7.87M | +1% |
| Avg. volume | 93.67K | 227.16K | -59% |
Peer median across 8 companies: SNGX, BOLT, AZTR, FBLG, CNSP, APRE, APUS, CURX.
Valuation
- Market cap
- $7.91M
- EPS (TTM)
- $-9.90
- Shares outstanding
- 3.04M
Price and trading
- Previous close
- 2.37
- Open
- 2.40
- Day range
- 2.34 – 2.60
- 52-week range
- 2.30 – 12.30
- Beta
- —
- Volume
- 58.44K
- Average volume
- 93.67K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 7.91M
- Forward Pe
- -1.62
- Eps
- -9.90
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.30
- Week52 Low
- 2.30
- Avg Volume
- 93,666.00
- Shares Outstanding
- 3.04M
- Ma50
- 5.74
- Ma200
- 6.95
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -79.84%
- Pct From52w Low
- 7.83%